Amine Saad Ph.D
About Amine Saad Ph.D
Amine Saad, Ph.D., is a Medical Scientist specializing in Hematology and Cell Therapy at Kite Pharma in Montreal, Quebec, Canada. He has extensive experience in oncology and research, having previously worked at the Montreal Jewish General Hospital and VBI Vaccines Inc.
Work at Kite Pharma
Amine Saad has been employed at Kite Pharma since 2021, serving as a Medical Scientist in the Hematology Cell Therapy division. Based in Montreal, Quebec, Canada, he has contributed to the development and implementation of cell therapies aimed at treating hematological malignancies. His role involves conducting research, collaborating with clinical teams, and advancing therapeutic strategies within the company.
Previous Experience in Oncology
Prior to joining Kite Pharma, Amine Saad worked at the Montreal Jewish General Hospital as a Clinical Team Lead in Oncology from 2016 to 2021. In this position, he oversaw clinical operations and supported oncology research initiatives. His experience in a hospital setting provided him with insights into patient care and treatment protocols in oncology.
Research Experience at VBI Vaccines Inc.
Amine Saad served as a Research Assistant at VBI Vaccines Inc. from 2008 to 2010. His work involved supporting vaccine development projects and conducting laboratory research. This role contributed to his foundational knowledge in immunology and vaccine science.
Teaching Assistant Role at University of Ottawa
From 2007 to 2010, Amine Saad was a Teaching Assistant at the University of Ottawa. In this capacity, he assisted in the instruction of undergraduate courses in microbiology and immunology. His role included preparing course materials, leading laboratory sessions, and providing support to students.
Education and Expertise
Amine Saad holds a Doctor of Philosophy (Ph.D.) in Experimental Medicine from McGill University, which he completed from 2011 to 2016. He also earned a Master's Degree in Microbiology and Immunology from the University of Ottawa from 2007 to 2010. Additionally, he obtained a Bachelor of Science (B.Sc.) in Biopharmaceutical Sciences from the University of Ottawa from 2002 to 2006. His educational background provides a strong foundation in medical science and research methodologies.